Sofinnova MD Start III is looking for early-stage medtech projects in need of both funding and operational support.

Eligible medtech projects should have a strong clinical impact and a high potential to improve how patients are treated. They should represent disruptive innovations whether in the form of new or augmented interventions, implants, treatment orientation solutions, including digitally-powered approaches.

Project stage should include from concept stage / ideation to first functional demonstrator / proof of concept in a preclinical model. Projects already incorporated into companies can be eligible as long as they do not have a complete management team in place and/or have not raised more than 1M€ in funding (dilutive or non-dilutive).

Projects should require financial support through funding from Sofinnova MD Start, and also operational support, fitting the Sofinnova MD Start model of a hands-on, joint project development with the project inventors.

The review and selection process will be conducted by the Sofinnova MD Start team, which consists of medical, science and engineering professionals, with extensive experience in medtech entrepreneurship and venture capital investment.

Proposals will be accepted until July 9th, 2021 via the online application form.